AMH’s ability to predict spontaneous pregnancy has been assessed across various populations, including healthy but predominantly obese women aged 30-44, cancer patients treated with GnRH, and young breast cancer patients not using fertility preservation (18–21). The gene discussed is AMH; the disease is breast carcinoma.